Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Evolva and Serodus sign EV-077 licensing agreement

Dec. 31, 2013

EMA accepts tolvaptan MAA for ADPKD

Dec. 27, 2013

Ampio spins off sexual dysfunction business into new company

Dec. 17, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Novel phosphate adsorbers for the treatment of patients with renal failure

Dec. 5, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Nov. 22, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Nov. 18, 2013

Kyowa Hakko Kirin discontinues phase II studies of bardoxolone methyl

Nov. 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...